|

FluBHPVE6E7 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • BlueSky Immunotherapies GmbH2

Indications

  • Cancer2
  • Oropharyngeal Squamous Cell Carcinoma (SCC)1
  • HPV-Related Cervical Carcinoma1
  • HPV Infection1

Other2 trials

Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer
Phase 1
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.